Thank You!
Thank you to everyone who attended the Discngine Meetup this year!
About the event
Once a year, we organize a Discngine Meetup event to bring together experts from different fields in drug discovery, cover innovative subjects in life science and technology, trigger discussions, and learn from each other. We give participants the opportunity to connect with the Discngine community and network with like-minded peers in an interactive virtual atmosphere.
We are excited to announce that our third Discngine Meetup event is coming up this year in October! The topic of the event is "New Drug Modalities: Evolving Needs in Scientific Informatics.” While drug discovery and development are advancing beyond small molecules thanks to technological innovation and emerging new modalities – such as oligonucleotides, PROTACs, RNA drugs, and gene and cell therapies, researchers are faced with modality-specific scientific and technological challenges.
During the 3-hour agenda, we will explore the progressive evolution of scientific informatics capabilities designed to facilitate the discovery of new drug modalities. Additionally, we will discuss effective strategies and solutions to overcome unmet needs in this rapidly advancing field.
By attending this event, you will gain insights and answers to the following questions:
Where are we now - How much are new modalities still challenging for research informatics?
Where do we go – Where and how can we expand our current IT capabilities to effectively support new discoveries?
How can we prepare ourselves to provide scientific and technical support to the next modality-type development?
A unique virtual experience
We are excited to host our event at Gather.Town virtual space!
With Gather, you will have the opportunity to navigate through a dynamic conference environment, where you can freely explore and engage with peers just as you would in a real-life setting.
We have tested this platform and are confident that Gather will provide you with an exceptional and immersive experience like no other. Get ready to enjoy a truly unique and interactive event!
Plenary Session
New Modalities: A Promise or a Pain-Point from a Drug Design Perspective
Leonardo De Maria, Ph.D. Principal Scientist at AstraZeneca
Talk Sessions
BioAIM: Building the Next Digital Biologics Platform for Large Molecules at Sanofi
Yves Fomekong Nanfack, Ph.D.
ED - Head of End to End AI Foundations. Large Molecules Research Platform at Sanofi
Data Science for New Modalities: Challenges and Opportunities
Barbara Brannetti, Ph.D.
Director Data Science, Characterization and Formulation at Novartis Institutes for BioMedical Research (NIBR)
Round Table
What is the State of the Art in New Drug Modalities Discovery? Present and Future Outlook
Chair
Thierry Dorval, Ph.D.
Head of Data Sciences & Data Management at Servier
Panelists
Philippe Archambault, Ph.D.
Application Scientist at Chemical Computing Group (CCG)
Kenneth Longo, Ph.D.
Vice President, Discovery Data Science at Wave Life Sciences
Barbara Brannetti, Ph.D.
Director Data Science, Characterization and Formulation at Novartis Institutes for BioMedical Research (NIBR)
Lars Brive, Ph.D.
Cheminformatics Data Scientist at AstraZeneca